Gilder Gagnon Howe & Co’s Q32 Bio QTTB Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-56	Closed	-$20K	–	297
2018 Q2	$20K	Hold	56	–	–	﹤0.01%	275
2018 Q1	$19K	Buy	+56	New	+$18.8K	﹤0.01%	287

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Gilder Gagnon Howe & Co's QTTB Position: Q3 2018 in Review

Gilder Gagnon Howe & Co sold out of Q32 Bio (QTTB) in Q3 2018, closing a stake of 56 shares — an estimated $20K sold.

Gilder Gagnon Howe & Co first reported a position in QTTB in Q1 2018 and held it in 2 quarters. The position peaked at $20K in Q2 2018. 50 funds tracked by Wall St. Rank hold QTTB as of Q3 2018.

Gilder Gagnon Howe & Co reported no remaining Q32 Bio position as of Q3 2018 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 56 Q32 Bio shares in Q3 2018, an estimated $20K.
Gilder Gagnon Howe & Co first reported a position in Q32 Bio in Q1 2018 and held it in 2 quarters.
Gilder Gagnon Howe & Co's Q32 Bio position peaked at $20K in Q2 2018.
50 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2018.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2018, filed 30 Oct 2018.